Status:
RECRUITING
Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
Lead Sponsor:
Sanford Health
Conditions:
Parkinsons Disease (PD)
Eligibility:
All Genders
Phase:
NA
Brief Summary
The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left dorsolateral prefrontal cortex (LDLPFC) will induce long-lasting effects in improving motor function and reducing motor...
Detailed Description
Parkinson's disease (PD) is the fastest growing and second most common neurodegenerative disease (after Alzheimer's disease) and affects approximately one million people in the United States. Impaired...
Eligibility Criteria
Inclusion
- Clinical diagnosis of PD with at least two of the four diagnostic criteria for PD (tremor, rigidity, bradykinesia, and postural instability)
- Must be able to consent
Exclusion
- Patients with dementia (MOCA \< 21)
- PD treatment using deep brain stimulation (DBS)
- Diagnosis of psychosis
- Diagnosis of multiple sclerosis
- Diagnosis of stroke
- Diagnosis of chronic obstructive pulmonary disease (COPD)
- Diagnosis of congestive heart failure (CHF)
Key Trial Info
Start Date :
November 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 11 2026
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06883266
Start Date
November 11 2024
End Date
December 11 2026
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanford Brain and Spine Center
Fargo, North Dakota, United States, 58103